Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:02 AM
Ignite Modification Date: 2025-12-25 @ 5:02 AM
NCT ID: NCT02455518
Eligibility Criteria: Inclusion Criteria: * Complaint of acute pain of \< 7 days duration * Location of pain in one or more extremities defined as distal to and including the shoulder joint in the upper extremities and distal to and including the hip joint in the lower extremities; * Radiologic evaluation is planned Exclusion Criteria: * Inability to confirm reliable means of phone followup. * Past use of methadone * Chronic condition requiring frequent pain management such as sickle cell disease, fibromyalgia, or any neuropathy * History of an adverse reaction to any of the study medications * Opioids taken in the past 24 hours * Ibuprofen or acetaminophen taken in past 8 hours * Pregnancy by either urine or serum HCG testing * Breastfeeding per patient report * History of peptic ulcer disease * Report of any prior use of recreational narcotics * Medical condition that might affect metabolism of opioid analgesics, acetaminophen, or ibuprofen such as hepatitis, renal insufficiency, hypo- or hyperthyroidism, Addison's or Cushing's disease * Taking any medicine that might interact with one of the study medications, such as antidepressant SSRI's or Tricyclics, antipsychotics, anti-malaria medications quinidine or halofantrine, Amiodarone or Dronedarone, diphenhydramine, celecoxib, ranitidine, cimetidine, ritanovir, terbinafine, or St John's Wort.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 21 Years
Maximum Age: 65 Years
Study: NCT02455518
Study Brief:
Protocol Section: NCT02455518